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Background: Non-tuberculous mycobacteria (NTM), which are ubiquitous micro-organisms occurring in humans,
animals and the environment, sometimes receive public health and veterinary attention as opportunistic
disease-causing agents. In Tanzania, there is limited information regarding the diversity of NTM species, particularly at
the human-livestock-wildlife interface such as the Serengeti ecosystem, where potential for cross species infection or
transmission may exist.
Methods: Mycobacterial DNA was extracted from cultured isolates obtained from sputum samples of 472 suspect
TB patients and 606 tissues from wildlife species and indigenous cattle. Multiplex PCR was used to differentiate NTM
from Mycobacterium tuberculosis complex (MTBC) members. NTM were further identified to species level by
nucleotide sequencing of the 16S rRNA gene.
Results: A total of fifty five (55) NTM isolates representing 16 mycobacterial species and 5 isolates belonging to the
MTBC were detected. Overall, Mycobacterium intracellulare which was isolated from human, cattle and wildlife, was
the most frequently isolated species (20 isolates, 36.4%) followed by M. lentiflavum (11 isolates, 20%), M. fortuitum
(4 isolates, 7.3%) and M. chelonae-abscessus group (3 isolates, 5.5%). In terms of hosts, 36 isolates were from cattle
and 12 from humans, the balance being found in various wildlife species.
Conclusion: This study reveals a diversity of NTM species in the Serengeti ecosystem, some of which have potential
for causing disease in animals and humans. The isolation of NTM from tuberculosis-like lesions in the absence of MTBC
calls for further research to elucidate their actual role in causing disease. We are also suggesting a one health approach
in identifying risk factors for and possible transmission mechanisms of the NTM in the agro-pastoral communities in the
Serengeti ecosystem.
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Non-tuberculous mycobacteria (NTM) are saprophytic
acid-fast bacilli, which are present in water, soil and bio-
films [1-3]. Various names such as anonymous, atypical,
environmental, opportunistic and mycobacteria other than
tubercle bacilli (MOTT) have been used interchangeably
referring to NTM [4]. In contrast to obligate parasites* Correspondence: bugwesa2002@yahoo.co.uk
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in the environment as saprophytes causing disease oppor-
tunistically [2,3]. Similarities of NTM isolates have been
found in humans and animals, soil and natural open water
sources, implying a possible transmission via the environ-
ment [3].
NTM play a significant role as sources of human and
animal infections [2,5] with varied clinical manifestations
[3] and should be a cause of concern in countries with high
prevalence of human immunodeficiency virus (HIV) infec-
tion [6]. In Tanzania, NTM species including M. gordonae,
M. smegmatis, M. fortuitum, M. phlei, M. flavescens andtd. This is an Open Access article distributed under the terms of the Creative
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ples collected from the coast region [7]. Studies conducted
in Arusha, northern Tanzania found NTM to be more
common than M. tuberculosis in patients with TB adenitis
[8]. Moreover, invasive NTM infections in Tanzania due
to M. sherrisii and M. avium complex sequevar M. avium
complex-D has been diagnosed in HIV-infected patients
[9], also NTM infection due to M. intracellulare has been
found to be associated with non-HIV infected patients
with a history of tuberculosis [10].
In the Serengeti ecosystem a very high interaction of
humans-environment-livestock- wildlife exists, posing a
risk for animal-and human-based contamination of the
natural water sources and the transmission of NTM to
other animals or humans [11]. However, little information
is available on NTM species circulating in humans, domes-
tic and wild animals and even fewer reports are available in
Africa, although Botha et al. [12] have reported that the
following NTMs have been found in human and animal
specimens: M. abscessus, M. asiaticum, M. avium, M.
brasilienses, M. chelonae, M. elephantis, M. engbackii,
M. farcinogenes, M. fortuitum, M. gilven, M. gordonae,
M. heraklionense, M. hiberniae, M. intracellulare, M.
interjectum, M. lentiflavum, M. marseillense, M. morio-
kaense, M. nonchromogenicum, M. palustre, M. palveris,
M. paraffinicum, M. phlei, M. senegalense, M. simiae,
M. sherrisii, M. sphagni, M. terrae and M. vulneris.
The use of molecular techniques that target the 16S
rRNA gene has been useful for diagnosis of NTM. This
is particularly important in TB endemic regions where
NTMs are underdiagnosed in TB patients due to limited
availability of laboratory facilities [13]. Most health centres
in developing countries depend on Ziehl-Neelsen (ZN)
for diagnosis of tuberculosis which cannot distinguish
M. tuberculosis complex (MTBC) from NTM [14,15].
Diagnosis of pathogens using molecular diagnostic tech-
niques is more rapid and improve accuracy in identifica-
tion as compared to conventional methods which are time
consuming [16]. Sequencing of the 16S rRNA gene in
NTM can be applied in the speciation of bacteria, even
those which are dead or are uncultivable [15,16]. There-
fore, we used this technique to determine species diversity
of NTM in biological samples collected from humans,
wildlife and livestock at the human-animal interface in
the Serengeti ecosystem, Tanzania.
Methods
Study site
This study was conducted in the Serengeti ecosystem and
surrounding districts in Bunda (S 2° 0' 0, E33° 49' 60),
Serengeti (S2° 0' 0, E 34° 49' 60) and Ngorongoro (E35°
and 36°E and S 2° and 4°) (Figure 1). The Serengeti ecosys-
tem as previously described by Katale et al. [17] is comprised
of Serengeti National Park (SNP), Ngorongoro ConservationArea (NCA), Loliondo Game Controlled Area (LGCA),
Maswa Game Reserve and Ikorongo-Grumeti Game
Reserve (IGGR). Livestock and wildlife in the ecosystem
interact during grazing and drinking water increasing
possibility of interspecies disease transmission or con-
tamination of water sources, which could potentially
lead to a zoonotic epidemic [17].
Sampling of livestock and wildlife tissues
Livestock
Four hundred and nighty nine (499) tissues (mediastinal,
retropharyngeal, pre-crural and pre-scapular lymphnodes,
lungs and liver) with lesions suggestive of mycobacterial
infection were collected from approximately 1200 slaugh-
tered indigenous zebu cattle (Bos indicus) in the Serengeti
(n = 420), Bunda (n = 600) and Ngorongoro (n = 180) abat-
toirs (Records from registry books, District Meat Inspec-
tion [2012–2013]). The slaughter houses were located in
district headquarters where cattle were purchased from
different local markets available in the districts and trans-
ported to district abattoirs for slaughter. Meat inspections
were conducted with assistance of meat inspectors at the
slaughter houses. To ensure that only cattle carcasses from
the study site were sampled, the history of the origin of
the cattle was taken from the owners. Tissues were se-
lected based on presence of tuberculous lesions in organs
and their associated lymph nodes. The anatomical sites of
bTB suspected lesions for each carcass were recorded.
With assistance from meat inspectors tuberculous organs
and their associated lymph nodes were palpated, incised
and preserved separately in sterile zip lock bags and
packed in a cool box before processing for storage in
liquid nitrogen containers.
Wildlife
One hundred and seven (107) wildlife tissues were sam-
pled opportunistically from dead animals in the Serengeti
ecosystem. Tissues sampled included road kill, where only
intact organs were sampled (2 impala and 1 black-backed
jackal), and animals that died from old age or disease.
Forty three (43) tissues which included mediastinal, ret-
ropharyngeal, mesenteric lympnodes, lungs, kidney and
liver were sampled during trophy and meat cropping in
Maswa Game Reserve (MGR) as per the schedule of the
Ministry of Natural Resources and Tourism, Tanzania.
Tissue specimens were preserved in liquid nitrogen
containers for further analysis. Ziehl-Neelsen (ZN) was
performed on tissues that showed growth on LJ Media.
Tissues processing and culture
Tissues of approximately 10 g were chopped into small
pieces using sterile scalpel blades and forceps and trans-
ferred into stomacher bags containing 10ml of sterile
Figure 1 Map of the Serengeti ecosystem which shows study sites where tissues from animals and sputum samples from TB suspect
patients were collected; A; Endulen Health centre, B; Bunda [Bunda district headquarter (HQ)], C; Mugumu (Serengeti district HQ),
D; Waso-Loliondo (Ngorongoro district HQ), E; Serengeti National Park, F; Maswa Game Reserve.
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using a blender (Stomacher 80 laboratory blender, Seward
Medical, London, UK). The homogenates were transferred
into universal containers, followed by addition of an equal
amount of 3% oxalic acid to the homogenate in the uni-
versal container. The suspensions were left for 45 minutes
at room temperature with occasional shaking before
centrifugation at 3000 rpm (Mistral 1000 MSE, UK) for
15 min. The sediments were neutralized with 3–4 drops
of 2% sodium hydroxide solution to which 3–4 drops of
0.1% phenol red indicator were added. The sediments
were mixed before inoculation on Lowenstein Jensen
(LJ) Media (BDH Chemicals Ltd, Poole, UK) containing
pyruvate or glycerol and incubated at 37°C. LJ slopes
were examined weekly for indications of macroscopic
growth for 12 weeks. When growth was visible, smears
were prepared, air dried, fixed with heat, stained with
ZN and examined microscopically for the presence of
acid fast bacilli (AFB).
Sputum sample collection and preparation for culture
Sputum samples were collected from 472 hospitalized and
out-patients who attended TB clinics in Bunda, Serengeti
and Ngorongoro district hospitals. Sputum samples were
collected in 50ml screw-cap Falcon tubes in the earlymorning. Both hospitalized and outpatients with symp-
toms suggestive of TB in the study area, new patients
who had not yet been started on anti-tuberculosis treat-
ment were considered for inclusion in the study. Digestion
and decontamination of sputum samples were carried out
by adding an equal volume of Cetyl Pyridinium Chloride
(CPC) solution to the sputum samples. The specimens
were left for 15 min at room temperature and concen-
trated by centrifuging at 4000rpm for 15 min. The su-
pernatants were poured off into a splash proof container.
Twenty (20) ml of distilled water was added to the sedi-
ments and the pellets were suspended by inverting the
tubes several times before centrifugation at 3500 rpm
for 15 min. The supernatant was poured off and the de-
posits were inoculated onto two slopes of LJ media contain-
ing glycerol or pyruvate by using sterile loops. Specimens
were incubated and examined weekly for bacterial growth.
Smears on microscope slides were prepared from the speci-
men sediments and thereafter stained by the Ziehl-Neelsen
(ZN) stain.
Extraction of DNA
Mycobacterial DNA was isolated from colonies of each
isolate that were scraped from the surface of the LJ
medium containing glycerol or pyruvate. The isolates
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sterile distilled water. The suspensions were heated in a
water bath at 80°C for 1 hour to inactivate the bacteria and
then centrifuged at 3000 rpm (Mistral 1000 MSE, UK) for
5 min. The supernatants were stored at − 80°C until further
analysis.
Mycobacterium genus typing
Multiplex PCR was performed using six primers as de-
scribed by Wilton & Cousins et al. [18]. Briefly, six oligo-
nucleotide primers namely MYCGEN-F 5’-AGA GTT
TGA TCC TGG CTC AG-3’, MYCGEN-R 5’-TGC ACA
CAG GCC ACA AGG GA-3’, which amplify a specific
PCR product from the 16s rRNA gene of all know myco-
bacteria were used. MYCAV-R 5’-ACC AGA AGA CAT
GCG TCT TG-3’ and MYCINT-F 5’-CCT TTA GGC
GCA TGT CTT TA-3’ which amplify the hyper variable
region of the 16S rRNA gene of M. intracellulare
(MYCINT-F) and M. avium (MYCAV-R) respectively.
Two primers (TB-F, TB-R) (TB-F 5’-GAA CAA TCC
GGA GTT GAC AA-3’ and TB-R 5’-AGC ACG CTG
TCA ATC ATG TA-3’ (TIB Molbiol® syntheselabor
GmbH, Germany) which target for the MPB70 gene were
used to specify M. tuberculosis complex from the myco-
bacteria. Briefly, one PCR reaction consisted of 2 μl DNA,
6.2 μl H20 Qiagen®, 10 μl of master mix and 0.3 μl for
each of the primers. Initially, DNA was denatured at 95°C
for 10 min, annealing involved 35 cycles for 1 min, 0.5 min
and 1 min at 95°C, 61°C and 72°C, respectively. Extension
was done at 72°C for 10 min and cooling at 4°C infinitely
at 4°C. In all cases of DNA amplification water was in-
cluded as negative controls and M. tuberculosis complex
DNA as positive controls in each run. Electrophoresis was
run at 100 V in 1.5% agarose (3.75 g in 250 ml of 1 × TAE
buffer) (Sigma®) gel and visualized under UV light. During
electrophoresis, Ethidium bromide was used as a staining
reagent. The PCR products were calibrated using hundred
base pair (100 bp) DNA ladder, blue loading dye (Promega
Corporation, Madison, USA).
Amplification of DNA for Mycobacterial speciation of NTM
PCR amplification of mycobacterial DNA samples was
done using 16S rRNA f- 5’ AGA GTT TGA TCC TGG
CTC AG 3’ and 16S rRNA r- 5’ GCG ACA AAC CAC
CTA CGA G 3’ primers. Each PCR reaction contained: 1
μl of DNA template, 2.5 μl of 10× buffer, 2 μl 25 mM
MgCl2, 1 μl 10 mM dNTPs, 5 μl Q-buffer, 0.5 μl of each
primer (50pmol/μl), 0.125 μl HotStarTaq DNA polymerase
(Qiagen, Germany) in a 24.5 μl reaction with ddH2O.
A negative control (no template) and a positive control
(DNA template from M. tuberculosis H37Rv) were in-
cluded to assay for contamination of the reagents and
successful PCR amplification, respectively. Amplification
was done by activating the Taq polymerase at 95°C for15 min, followed by 45 cycles of 94°C for 30 s, 60°C for
1 min and 72°C for 30 s, followed by a final elongation
step at 72°C for 10 min.
Nucleotide sequencing of non-tuberculous mycobacteria
To identify mycobacterial species, polymerase chain re-
actions (PCRs) were conducted followed by sequencing
of the 16S rRNA gene [19] using 1.1pmol/µl16S rRNA
forward primer (16S-27f (5'- GWA TTA CCGCGG CKG
CTG -3'). Sequencing was done using an ABI sequencer
(Applied Biosystem Inc.) at the Central Analytical Facility
(CAF) of Stellenbosch University, South Africa. Accession
numbers and obtained sequences were edited and analysed
using the Ribosomal Differentiation of Microorganisms
(RIDOM) project (http://www.ridom-rdna.de) and the
National Center for Biotechnology Information (NCBI)
Blast sequence alignment tool (http://blast.ncbi.nlm.nih.gov).
Ethical consideration
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Results
The 606 tissue specimens collected from livestock and
wildlife species showed that 5 specimens (0.8%) were iden-
tified as MTBC members and 43 specimens (7.1%) were
characterized as NTM species, which consisted mostly of
M. intracellulare (20 of the 43 samples, 46.5%). Other
NTM species identified were M. lentiflavum isolated from
6 cattle specimens, 3 buffalo specimens, 1 Thompson
gazelle specimen and 1 isolate from a warthog. M. simiae,
M. confluentis, M. neoaurum, M. nonchromogenicum, M.
terrae and M. thermoresistibile were isolated from cattle
only (see Table 1). No growth was observed for the other
558 (92.1%) tissue specimens cultured on LJ medium.
From the 472 human sputum samples, only 12 specimens
(2.9%) were NTM positive which wereM. Chelonae-abscessus
group (n = 3), M. genavense, M. gilvum, M. gordonae,
M. intermedium, M. poriferae and M. spaghni (n = 2).
No M. avium species were identified from human or
animal specimens. Most of NTM species isolated in this
study have been found in other countries such as Uganda,
Kenya, Zambia and South Africa (Table 2). No report
was found whether M. genavense, M. poriferae and M.
spaghi have been isolated in these countries (Table 2). All
members of the mycobacteria genus gave a PCR
Table 1 Species diversity of NTM isolated from humans,
livestock and wildlife based on sequencing of 16S rRNA
gene
NTM Species Host
M .lentiflavum 6 cattle, 3 buffalo, 1 Thompson gazelle,
1 warthog
M .simiae 2 cattle
M. chelonae-abscessus 3 human
M. confluentis 1 cattle
M. fortuitum 3 cattle, 1 human
M. genavanse 1 human
M. gilvum 1 human
M. gordonae 1 human
M. intermedium 1 human
M. intracellulare 17 cattle, 1 human, 1 Thompson gazelle,
1 baboon
M. neoaurum 2 cattle
M. nonchromogenicum 2 cattle
M. poriferae 1 human
M. spaghni 2 human
M. terrae 2 cattle
M. thermoresistibile 1 cattle
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fragment of 850 bp in addition to the 1030 bp genus
product. PCR fragments of 372 bp in addition to the
1030 bp product were generated by isolates from the
M. tuberculosis complex.Discussion
We found the overall prevalence of NTM in livestock
and wildlife to be 7.1%, which is not far from results
estimated based on comparative skin tests conducted
in the same ecosystem in indigenous cattle. This study
showed non-specific reaction (atypical mycobacterium)
to avian and bovine tuberculin purified proteins deriv-
atives (PPDs) to be 10.6% in indigenous zebu [17]. How-
ever, we were unable to find either NTM or MTBC in a
high proportion (92.1%) of tissues with apparent tubercu-
lous lesions, indicating that the lesions might be caused by
other pathogens or there was a failure of egg based LJ
medium to culture mycobacteria from these lesions. Li-
quid media is more efficient for recovery of mycobacteria
than egg based solid medium [20]. A report by McCarthy
et al. [21] found large differences in recovery of NTM be-
tween solid or liquid media, a study that cultured NTM
from patients with HIV. However, in the present study li-
quid medium was not used for isolation of mycobacter-
ium. Neither, was the HIV status of human TB suspected
patients available to correlate the NTM infection with
HIV status.This study has shown that, 16 species of NTM were
isolated from humans, indigenous cattle and wildlife, in
the Serengeti ecosystem, of which the majority were M.
intracellulare, M. lentiflavum and M. fortuitum. Other
NTM species including M. cholenae-abscessus group, M.
simiae, M. neoaurum, M. nonchromogenicum, M. spaghni,
M. terrae, M. confluentis, M. genavense, M. gilvum, M.
gordonae, M. intermedium, M. poriferae and M. thermore-
sistibile were isolated at a lower rate, ranging between
5.5% and 1.8%. Comparison of the NTM species iso-
lated in this study indicate that most of them have pre-
viously been found in humans, animals, or the environment
in Ethiopia, Kenya, Uganda, South Africa and Zambia
(Table 2). In the present study, given the nature of sample
acquisition for both cattle and wildlife specimens, isolation
of M. gordonae and M. terrae complex as environmental
contaminants [22] might occur. Thus there is unjustifiable
potential for specimens’ environmental contamination
which might obscure our findings. M. genavense, M.
poriferae and M. spaghni are not common or have not
previously been isolated in East Africa (Table 2). In con-
trast to our study where all NTM species were isolated
from sputum samples and animals tissues. Previous
studies found M .simiae, M. fortuitum, M. gordonae, M.
intermedium, M. intracellulare, M. nonchromogenicum
and M. terrae in soil and water (Table 2). The correlation
of NTM between soil on one hand and animals on the
other hand indicates that NTM are readily exchanged
between animals and environments [23]. However, in our
study no any environmental sample was taken to correlate
between NTM species found in animals and environments.
M. intracellulare, which is a member of Mycobacterium
avium complex (MAC) was the most frequently isolated
species, consistent with a report from study of NTM in
Uganda, South Africa and Australia [24,25]. However, this
finding differs from other studies in Kenya, South Africa
and Uganda where M. mucogenicum, M. terrae and M.
fortuitum were the most frequently isolated species re-
spectively [14,16]. The high prevalence of M. intracellulare
is of concern in this setting, given a high HIV prevalence
and the ability of M. intracellulare to cause pulmonary
and extrapulmonary TB in such individuals [26,27] such
as has been reported in Kenya [28]. In the current study,
M. intracellulare species were isolated from human, cattle
and wildlife.
We also found M. fortuitum, M. chelonae-abscessus
group, M. genavense, M. gilvum, M. gordonae, M. inter-
medium, M. poriferae and M. spaghni in TB suspect
patients who had clinical signs suggestive of tuberculosis.
However the role of these NTM in TB disease causation
as well as possible influence in the diagnostic tests for
tuberculosis is not known in our cases. This finding is
consistent with previous studies where these species were
isolated from respiratory samples from patients with
Table 2 Comparison of species diversity of NTM in Tanzania with other Sub-Saharan African countries
NTM spp Culture source Host/source Country Reference
M .lentiflavum Sputum, animals
tissues
Human, animals Zambia, Uganda,
Kenya, Zambia
Muyoyeta et al. [20], Asiimwe et al. [14], Mijele et al. [21],
Buijtels et al. [22], Buijtels et al. [23], Panagiotou et al. [24]
M .simiae Water, soil Animals, environment Uganda, South
Africa
Kankya et al. [25], Gcebe et al. [26]
M. chelonae Sputum, animal
tissues
Human, animals Zambia, Uganda Panagiotou et al. [24], Muwonge et al. [27]
M. confluentis Soil, animal tissues,
sputum
Animals, environment,
human
South Africa,
Ethiopia
Gcebe et al. [26], Workalemahu et al. [28]
M. fortuitum Sputum, soil, water,
faecal, animal tissues
Human, environment,
animals
Zambia, Uganda,
Kenya, Ethiopia
Muyoyeta et al. [20], Kankya et al. [25], Nyamogoba et al. [29],
Berge et al. [30], Workalemahu et l. [28], Buijtels et al. [23],
Panagiotou et al. [24], Muwonge et al. [27]
M. genavanse * * * *
M. gilvum Sputum Human Zambia Buijtels et al. [23]
M. gordonae Sputum, water, soil,
animal tissues
Animals, Human,
environment
Zambia, Uganda,
South Africa,
Kenya, Ethiopia
Muyoyeta et al. [20], Kankya et al. [25], Asiimwe et al. [14],
Gcebe et al. [26], Mijele et al. [21], Berge et al. [30],
Amen et al.[31], Buijtels et al. [23], Panagiotou et al. [24],
Muwonge et al. [27]
M. intermedium Soil, water Animals, environment South Africa Gcebe et al. [26]
M. intracellulare Water, soil, sputum,
animal tissues
Human, environment,
animals
Uganda, Kenya,
Ethiopia, Zambia
Kankya et al. [25], Asiimwe et al. [14], Nyamogoba et al. [29],
Mijele et al. [21], Berge et al. [30], Buijtels et al. [32],
Buijtels et al. [23], Panagiotou et al. [24]
M. neoaurum Animal tissues Animals Uganda Muwonge et al. [27]
M. nonchromogenicum Water, soil, animal
tissues, swabs
Animals, environment Uganda, South
Africa, Ethiopia
Kankya et al. [25], Gcebe et al. [26], Berge et al. [30]
M. poriferae * * * *
M. spaghni * * * *
M. terrae Water, animal tissues,
soil, sputum
Animals, environment,
human
South Africa,
Ethiopia, Zambia,
Uganda
Kankya et al. [25], Gcebe et al. [26], Workalemahu et al. [28],
Buijtels et al. [23], Muwonge et al. [27]
M. thermoresistibile Soil Environment South Africa Gcebe et al. [26]
*No report is available from other countries.
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and healed pulmonary TB [29-32]. In Uganda, M. fortui-
tum was the most prevalent NTM species isolated from
respiratory secretions in infants and adolescence [13].
We isolated from tuberculous lesions of indigenous cat-
tle a number of NTM species which include M. simiae,
M. confluentis, M. neoaurum, M. nonchromogenicum,
M. terrae and M. thermoresistibile. Apparently these
animals had neither M. bovis nor other MTBC and it
may be important to examine the role of these NTM in
disease causation. It is also potentially important to test
the effect of exposure of animals to NTM on the speci-
ficity and/or sensitivity of bovine tuberculosis (bTB) diag-
nostic test [33] such as skin test and interferon gamma
assay due to potential cross-reactivity.
Lastly, we detected a low prevalence of M. nonchromo-
genicum in cattle and M. lentiflavum from indigenous
cattle and wildlife. M. nonchromogenicum, part of the M.
terrae complex, has also been isolated from nasal mucus
from cattle in a herd infected with bTB [34] and in im-
munosuppressed individuals with pulmonary disease [35].Infections due to M. terrae complex are rare [36]. How-
ever, M. nonchromogenicum has been associated with
bacteremia in AIDS patients [25], lung infection in humans
and has been detected from patients with chronic skin
ulcers unresponsive to antibiotic treatment, arthritis [37],
tenosynovitis [38], pulmonary infection [37,39] and men-
ingitis [40], signifying its public health and veterinary im-
portance. Together with M, terrae, M. nonchromogenicum
is widely distributed in Africa although proportions differ
in different countries [23].
The ubiquitous nature of NTM suggests value for
investigation of their clinical relevance as well as effects
on interpreting other positive TB test results, for example,
we do not know what the influence of NTM on immunity
and immunological based TB diagnostic tests, given the
fact that mycobacteria share many common antigens.
Conclusion
In conclusion, there is a very wide range of NTM species
from humans and animals in the Serengeti ecosystem and
understanding their transmission dynamics will require a
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of samples from livestock, wildlife, humans and their
environment. Furthermore, there is a need to investigate
the influence of NTM in disease causation and efficacy on
screening and diagnostic tests.
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